90
Participants
Start Date
August 1, 2024
Primary Completion Date
December 31, 2025
Study Completion Date
June 30, 2026
Vutiglabridin
Once-daily oral administration
Placebo
Once-daily oral administration
RECRUITING
The Catholic University of Korea Uijeongbu St.Marys Hostpial, Uijeongbu-si
RECRUITING
Hallym University Medical Center, Anyang-si
RECRUITING
Inje University Busan Paik Hospital, Busan
RECRUITING
Inje University Sanggye Paik Hospital, Seoul
RECRUITING
KyungHee University Medical Center, Seoul
RECRUITING
Severance Hospital, Seoul
RECRUITING
Samsung Medical Center, Seoul
RECRUITING
The Catholic University of Korea, Seoul
RECRUITING
Korea University Guro Hospital, Seoul
Lead Sponsor
The Catholic University of Korea
OTHER
Kyunghee University Medical Center
OTHER
Korea University Guro Hospital
OTHER
Samsung Medical Center
OTHER
Severance Hospital
OTHER
Inje University
OTHER
Hallym University Medical Center
OTHER
The Catholic University of Korea Uijeongbu St.Marys Hostpial
UNKNOWN
Glaceum
INDUSTRY